A review of the use of trastuzumab (Herceptin®) plus vinorelbine in metastatic breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/18/7/1152/639355/mdl476.pdf
Reference30 articles.
1. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005;Goldhirsch;Ann Oncol,2005
2. Current perspectives on HER2 testing: a review of national testing guidelines;Bilous;Mod Pathol,2003
3. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology;Bast;J Clin Oncol,2001
4. Maximizing clinical benefit with trastuzumab;Bell;Semin Oncol,2004
5. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Marty;J Clin Oncol,2005
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications;The Journal of Liquid Biopsy;2023-12
2. Development and validation of a potential biomarker to improve the assessment of liver fibrosis progression in patients with chronic hepatitis B;Journal of Medical Virology;2022-10-27
3. Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells;JCO Precision Oncology;2021-05
4. Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review;Journal of Oncology Pharmacy Practice;2021-03-31
5. Third-line treatment of HER2-positive advanced breast cancer: From no standard to a Pandora's box;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3